77 results
8-K
MEIP
MEI Pharma Inc
18 Dec 23
Submission of Matters to a Vote of Security Holders
4:00pm
on Executive Compensation.
Proposal 3 was to approve, on an advisory basis, on the frequency of the approved, on an advisory basis … Years
Abstain
Broker Non-Votes
Based upon these results, the Board has determined that MEI Pharma will hold an advisory vote on executive compensation every
DEFC14A
Anson Funds Management LP
10 Oct 23
Proxy in contested solicitation
10:33am
EXECUTIVE COMPENSATION AND DIRECTOR COMPENSATION, INFORMATION CONCERNING THE COMMITTEES OF THE BOARD AND OTHER INFORMATION CONCERNING THE BOARD
PREC14A
02a05ow7zyfob
2 Oct 23
Preliminary proxy with contested solicitation
8:42am
DEFC14A
bd6a4 7jmr
26 Sep 23
Proxy in contested solicitation
3:42pm
PRRN14A
4kxwn9ljgaay04h 0f
4 Aug 23
Revised preliminary proxy statement filed by non-management
5:15pm
PREC14A
j469ev vbxmv
17 Jul 23
Preliminary proxy with contested solicitation
9:15am
425
24e5ht4agt0ol
13 Jun 23
Business combination disclosure
4:10pm
8-K
EX-10.3
ppwh65hpqkqgdk54
13 Jun 23
MEI Pharma Announces Planned Departure of Chief Financial Officer Brian
4:01pm
424B3
th72e7k
6 Jun 23
Prospectus supplement
4:19pm
8-K
d6s98
17 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:45pm